ReCode Therapeutics Competitors and Similar CompaniesClear all
ReCode Therapeutics's competitors and similar companies include BillionToOne, Verona Pharma and Breath Therapeutics.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases. |  Breath Therapeutics Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date N/A | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Menlo Park, US HQ | Locations Menlo Park, US HQ | Locations London, GB HQ Cardiff, GB Raleigh, US | Locations Dieburg, DE HQ München, DE Cambridge, US |
Employees | Employees 1062% decrease | Employees 620 | Employees 79 | Employees N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $305.1m (FY, 2025) | Revenue (est.) $42.3m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $96.7m (FY, 2025) | Cost of goods $1.4m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $208.5m (FY, 2025) | Gross profit $40.9m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income $7.5m (FY, 2025) | Net income ($173.2m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 82m | Total funding raised $ 87.5m | Total funding raised $ 11.5m | Total funding raised $ 46m |
For sources of this data, please see the company profile
View Company Profiles
BillionToOne
HQ
Menlo Park, US
Employees
620
BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.
View companyVerona Pharma
HQ
London, GB
Employees
79
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
View companyBreath Therapeutics
HQ
Dieburg, DE
Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases.
View company